AxoGen, Inc. (AXGN)
USD 16.14
(-5.28%)
USD 16.14
(-5.28%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 127.87 Million USD | 11.74% |
| 2022 | 114.43 Million USD | 9.59% |
| 2021 | 104.42 Million USD | 15.11% |
| 2020 | 90.71 Million USD | 1.52% |
| 2019 | 89.36 Million USD | 25.84% |
| 2018 | 71.01 Million USD | 38.93% |
| 2017 | 51.11 Million USD | 47.56% |
| 2016 | 34.64 Million USD | 54.08% |
| 2015 | 22.48 Million USD | 68.09% |
| 2014 | 13.37 Million USD | 57.22% |
| 2013 | 8.5 Million USD | 48.48% |
| 2012 | 5.72 Million USD | 136.48% |
| 2011 | 2.42 Million USD | 2554.59% |
| 2010 | 91.27 Thousand USD | -99.63% |
| 2009 | 24.91 Million USD | 34160.81% |
| 2008 | 72.71 Thousand USD | -27.6% |
| 2007 | 100.43 Thousand USD | -20.71% |
| 2006 | 126.66 Thousand USD | -71.43% |
| 2005 | 443.35 Thousand USD | -58.37% |
| 2004 | 1.06 Million USD | -38.85% |
| 2003 | 1.74 Million USD | 6.22% |
| 2002 | 1.63 Million USD | -69.76% |
| 2001 | 5.42 Million USD | -10.06% |
| 2000 | 6.02 Million USD | 20.58% |
| 1999 | 5 Million USD | 11.11% |
| 1998 | 4.5 Million USD | -16.67% |
| 1997 | 5.4 Million USD | -11.48% |
| 1996 | 6.1 Million USD | -7.58% |
| 1995 | 6.6 Million USD | 43.48% |
| 1994 | 4.6 Million USD | 17.95% |
| 1993 | 3.9 Million USD | 8.33% |
| 1992 | 3.6 Million USD | 9.09% |
| 1991 | 3.3 Million USD | 10.0% |
| 1990 | 3 Million USD | -3.23% |
| 1989 | 3.1 Million USD | -3.13% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 35.34 Million USD | 8.35% |
| 2024 Q1 | 32.62 Million USD | -3.39% |
| 2023 Q1 | 29.95 Million USD | -0.23% |
| 2023 Q2 | 30.92 Million USD | 3.24% |
| 2023 Q3 | 33.22 Million USD | 7.44% |
| 2023 FY | 127.87 Million USD | 11.74% |
| 2023 Q4 | 33.76 Million USD | 1.61% |
| 2022 Q3 | 30.78 Million USD | 9.28% |
| 2022 Q4 | 30.02 Million USD | -2.47% |
| 2022 FY | 114.43 Million USD | 9.59% |
| 2022 Q1 | 25.46 Million USD | -2.48% |
| 2022 Q2 | 28.17 Million USD | 10.64% |
| 2021 Q4 | 26.1 Million USD | 0.55% |
| 2021 Q2 | 26.48 Million USD | 2.41% |
| 2021 Q1 | 25.86 Million USD | -4.32% |
| 2021 Q3 | 25.96 Million USD | -1.97% |
| 2021 FY | 104.42 Million USD | 15.11% |
| 2020 Q1 | 19.44 Million USD | -16.48% |
| 2020 FY | 90.71 Million USD | 1.52% |
| 2020 Q2 | 16.51 Million USD | -15.09% |
| 2020 Q3 | 27.73 Million USD | 67.95% |
| 2020 Q4 | 27.03 Million USD | -2.52% |
| 2019 Q3 | 24.05 Million USD | 7.11% |
| 2019 Q1 | 19.57 Million USD | -1.12% |
| 2019 Q2 | 22.45 Million USD | 14.75% |
| 2019 FY | 89.36 Million USD | 25.84% |
| 2019 Q4 | 23.28 Million USD | -3.21% |
| 2018 Q2 | 17.47 Million USD | 20.15% |
| 2018 Q1 | 14.54 Million USD | 1.33% |
| 2018 Q3 | 19.19 Million USD | 9.83% |
| 2018 FY | 71.01 Million USD | 38.93% |
| 2018 Q4 | 19.79 Million USD | 3.11% |
| 2017 Q4 | 14.35 Million USD | 6.02% |
| 2017 FY | 51.11 Million USD | 47.56% |
| 2017 Q2 | 12.89 Million USD | 24.85% |
| 2017 Q3 | 13.54 Million USD | 5.05% |
| 2017 Q1 | 10.32 Million USD | 7.79% |
| 2016 FY | 34.64 Million USD | 54.08% |
| 2016 Q4 | 9.57 Million USD | 0.75% |
| 2016 Q2 | 8.84 Million USD | 31.93% |
| 2016 Q3 | 9.5 Million USD | 7.46% |
| 2016 Q1 | 6.7 Million USD | 4.89% |
| 2015 Q3 | 6.74 Million USD | 25.4% |
| 2015 Q1 | 3.96 Million USD | 3.43% |
| 2015 FY | 22.48 Million USD | 68.09% |
| 2015 Q4 | 6.39 Million USD | -5.19% |
| 2015 Q2 | 5.37 Million USD | 35.5% |
| 2014 Q2 | 3.32 Million USD | 36.5% |
| 2014 FY | 13.37 Million USD | 57.22% |
| 2014 Q1 | 2.43 Million USD | 2.02% |
| 2014 Q3 | 3.77 Million USD | 13.49% |
| 2014 Q4 | 3.83 Million USD | 1.63% |
| 2013 FY | 8.5 Million USD | 48.48% |
| 2013 Q4 | 2.38 Million USD | 3.53% |
| 2013 Q3 | 2.3 Million USD | 3.51% |
| 2013 Q2 | 2.22 Million USD | 40.84% |
| 2013 Q1 | 1.58 Million USD | 1.04% |
| 2012 Q4 | 1.56 Million USD | 8.88% |
| 2012 Q3 | 1.43 Million USD | -4.77% |
| 2012 Q2 | 1.51 Million USD | 24.4% |
| 2012 Q1 | 1.21 Million USD | 46.56% |
| 2012 FY | 5.72 Million USD | 136.48% |
| 2011 Q4 | 828.51 Thousand USD | 7839.0% |
| 2011 FY | 2.42 Million USD | 2554.59% |
| 2011 Q1 | 3.62 Million USD | 8506.99% |
| 2011 Q2 | 2.24 Million USD | -38.09% |
| 2011 Q3 | 10.43 Thousand USD | -99.53% |
| 2010 FY | 91.27 Thousand USD | -99.63% |
| 2010 Q4 | 42.11 Thousand USD | 59.7% |
| 2010 Q1 | 19.52 Thousand USD | -99.92% |
| 2010 Q2 | 3254.00 USD | -83.34% |
| 2010 Q3 | 26.37 Thousand USD | 710.48% |
| 2009 FY | 24.91 Million USD | 34160.81% |
| 2009 Q1 | 42.1 Thousand USD | 29.22% |
| 2009 Q2 | 610.31 Thousand USD | 1349.43% |
| 2009 Q3 | 24.21 Thousand USD | -96.03% |
| 2009 Q4 | 24.23 Million USD | 99981.53% |
| 2008 Q4 | 32.58 Thousand USD | 132.39% |
| 2008 Q2 | 5075.00 USD | -75.87% |
| 2008 Q1 | 21.02 Thousand USD | 0.0% |
| 2008 FY | 72.71 Thousand USD | -27.6% |
| 2008 Q3 | 14.02 Thousand USD | 176.3% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 FY | 100.43 Thousand USD | -20.71% |
| 2006 FY | 126.66 Thousand USD | -71.43% |
| 2006 Q4 | - USD | -100.0% |
| 2006 Q3 | 34.38 Thousand USD | 0.0% |
| 2006 Q2 | - USD | -100.0% |
| 2006 Q1 | 92.27 Thousand USD | -63.69% |
| 2005 Q3 | 68.71 Thousand USD | 203.1% |
| 2005 FY | 443.35 Thousand USD | -58.37% |
| 2005 Q4 | 254.15 Thousand USD | 269.86% |
| 2005 Q2 | -66.65 Thousand USD | -181.99% |
| 2005 Q1 | 81.29 Thousand USD | 0.0% |
| 2004 Q1 | 745.76 Thousand USD | 43.46% |
| 2004 Q3 | - USD | -100.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q2 | 373.27 Thousand USD | -49.95% |
| 2004 FY | 1.06 Million USD | -38.85% |
| 2003 Q3 | 339.47 Thousand USD | -13.18% |
| 2003 Q4 | 519.84 Thousand USD | 53.13% |
| 2003 Q1 | 491.29 Thousand USD | 452.08% |
| 2003 FY | 1.74 Million USD | 6.22% |
| 2003 Q2 | 391 Thousand USD | -20.41% |
| 2002 Q2 | 468 Thousand USD | -4.17% |
| 2002 FY | 1.63 Million USD | -69.76% |
| 2002 Q3 | 594.27 Thousand USD | 26.98% |
| 2002 Q4 | 88.99 Thousand USD | -85.03% |
| 2002 Q1 | 488.35 Thousand USD | 0.0% |
| 2001 Q3 | 941 Thousand USD | 88.14% |
| 2001 FY | 5.42 Million USD | -10.06% |
| 2001 Q1 | 1.6 Million USD | 5.22% |
| 2001 Q2 | 500.15 Thousand USD | -68.78% |
| 2000 FY | 6.02 Million USD | 20.58% |
| 2000 Q2 | 1.8 Million USD | 5.17% |
| 2000 Q1 | 1.71 Million USD | 22.79% |
| 2000 Q4 | 1.52 Million USD | -15.35% |
| 2000 Q3 | 1.79 Million USD | -0.53% |
| 1999 Q1 | 1.3 Million USD | 18.18% |
| 1999 Q2 | 1.3 Million USD | 0.0% |
| 1999 Q3 | 1.1 Million USD | -15.38% |
| 1999 Q4 | 1.4 Million USD | 27.27% |
| 1999 FY | 5 Million USD | 11.11% |
| 1998 FY | 4.5 Million USD | -16.67% |
| 1998 Q3 | 1.2 Million USD | 20.0% |
| 1998 Q4 | 1.1 Million USD | -8.33% |
| 1998 Q2 | 1 Million USD | 0.0% |
| 1998 Q1 | 1 Million USD | -9.09% |
| 1997 Q1 | 1.3 Million USD | 0.0% |
| 1997 FY | 5.4 Million USD | -11.48% |
| 1997 Q4 | 1.1 Million USD | -21.43% |
| 1997 Q3 | 1.4 Million USD | 0.0% |
| 1997 Q2 | 1.4 Million USD | 7.69% |
| 1996 FY | 6.1 Million USD | -7.58% |
| 1996 Q3 | 1.4 Million USD | 16.67% |
| 1996 Q4 | 1.3 Million USD | -7.14% |
| 1996 Q2 | 1.2 Million USD | -33.33% |
| 1996 Q1 | 1.8 Million USD | 20.0% |
| 1995 Q3 | 1.7 Million USD | 6.25% |
| 1995 Q1 | 1.9 Million USD | 26.67% |
| 1995 FY | 6.6 Million USD | 43.48% |
| 1995 Q4 | 1.5 Million USD | -11.76% |
| 1995 Q2 | 1.6 Million USD | -15.79% |
| 1994 Q1 | 900 Thousand USD | -10.0% |
| 1994 Q3 | 1.5 Million USD | 25.0% |
| 1994 FY | 4.6 Million USD | 17.95% |
| 1994 Q4 | 1.5 Million USD | 0.0% |
| 1994 Q2 | 1.2 Million USD | 33.33% |
| 1993 FY | 3.9 Million USD | 8.33% |
| 1993 Q3 | 1.4 Million USD | 40.0% |
| 1993 Q4 | 1 Million USD | -28.57% |
| 1993 Q1 | 1 Million USD | 25.0% |
| 1993 Q2 | 1 Million USD | 0.0% |
| 1992 Q2 | 800 Thousand USD | -20.0% |
| 1992 Q4 | 800 Thousand USD | -27.27% |
| 1992 Q3 | 1.1 Million USD | 37.5% |
| 1992 Q1 | 1 Million USD | 11.11% |
| 1992 FY | 3.6 Million USD | 9.09% |
| 1991 Q1 | 800 Thousand USD | -11.11% |
| 1991 Q4 | 900 Thousand USD | 0.0% |
| 1991 FY | 3.3 Million USD | 10.0% |
| 1991 Q3 | 900 Thousand USD | 12.5% |
| 1991 Q2 | 800 Thousand USD | 0.0% |
| 1990 FY | 3 Million USD | -3.23% |
| 1990 Q2 | -6.4 Million USD | -223.08% |
| 1990 Q1 | 5.2 Million USD | 57.58% |
| 1990 Q4 | 900 Thousand USD | 12.5% |
| 1990 Q3 | 800 Thousand USD | 112.5% |
| 1989 Q1 | 1.6 Million USD | -5.88% |
| 1989 FY | 3.1 Million USD | -3.13% |
| 1989 Q4 | 3.3 Million USD | 266.67% |
| 1989 Q3 | 900 Thousand USD | -43.75% |
| 1989 Q2 | 1.6 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 2.55 Million USD | -4914.667% |
| BrainsWay Ltd. | 23.09 Million USD | -453.783% |
| Cerus Corporation | 86.4 Million USD | -48.002% |
| Envoy Medical, Inc. | -473 Thousand USD | 27134.672% |
| electroCore, Inc. | 13.22 Million USD | -866.838% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -209529.508% |
| IceCure Medical Ltd | 1.3 Million USD | -9736.462% |
| Inogen, Inc. | 126.69 Million USD | -0.927% |
| OrthoPediatrics Corp. | 111.25 Million USD | -14.94% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 2213.62% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 270241.119% |
| MaxCyte, Inc. | 36.54 Million USD | -249.899% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -27910.786% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -150233.882% |
| Orthofix Medical Inc. | 486.27 Million USD | 73.703% |
| PAVmed Inc | -3.96 Million USD | 3322.631% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 2431.34% |
| RxSight, Inc. | 53.76 Million USD | -137.839% |
| Sight Sciences, Inc. | 69.17 Million USD | -84.856% |
| SI-BONE, Inc. | 109.42 Million USD | -16.865% |
| TELA Bio, Inc. | 40.11 Million USD | -218.792% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 15.837% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | -1446.052% |
| Acutus Medical, Inc. | -3.13 Million USD | 4176.315% |
| Talis Biomedical Corporation | 371 Thousand USD | -34367.385% |
| Spectral AI, Inc. | 7.88 Million USD | -1522.766% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 2039.836% |
| CVRx, Inc. | 33.03 Million USD | -287.04% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -17191.346% |
| Bioventus Inc. | 328.19 Million USD | 61.037% |
| Venus Concept Inc. | 52.16 Million USD | -145.124% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | -703.936% |
| LivaNova PLC | 771.25 Million USD | 83.42% |
| 908 Devices Inc. | 25.32 Million USD | -404.992% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 58.777% |
| Nemaura Medical Inc. | -1.47 Million USD | 8761.25% |
| NeuroPace, Inc. | 48.12 Million USD | -165.729% |
| LENSAR, Inc. | 21.1 Million USD | -505.837% |
| Apyx Medical Corporation | 14.12 Million USD | -805.495% |
| Cutera, Inc. | 41.49 Million USD | -208.175% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | -592.671% |
| BioSig Technologies, Inc. | 18 Thousand USD | -710311.111% |
| Anika Therapeutics, Inc. | 103.08 Million USD | -24.044% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | -839.283% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 85.606% |
| Axonics, Inc. | 274.55 Million USD | 53.425% |
| Outset Medical, Inc. | 29 Million USD | -340.945% |
| IRIDEX Corporation | 21.8 Million USD | -486.39% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | -79.98% |
| IRadimed Corporation | 50.15 Million USD | -154.941% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -44455.401% |
| INVO Bioscience, Inc. | 1.08 Million USD | -11673.274% |
| Telesis Bio, Inc. | 16.95 Million USD | -654.419% |
| Viemed Healthcare, Inc. | 112.78 Million USD | -13.381% |
| Varex Imaging Corporation | 256.9 Million USD | 50.224% |
| Quipt Home Medical Corp. | 163.84 Million USD | 21.954% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 31596.059% |
| Pulmonx Corporation | 50.75 Million USD | -151.959% |
| Dynatronics Corporation | 7.63 Million USD | -1574.844% |
| Modular Medical, Inc. | -768 Thousand USD | 16750.26% |
| ReShape Lifesciences Inc. | 5.54 Million USD | -2204.867% |
| Semler Scientific, Inc. | 61.2 Million USD | -108.944% |
| InMode Ltd. | 411.34 Million USD | 68.913% |
| Bruker Corporation | 1.51 Billion USD | 91.569% |
| Cytosorbents Corporation | 22.39 Million USD | -471.069% |
| DexCom, Inc. | 2.28 Billion USD | 94.413% |
| Align Technology, Inc. | 2.71 Billion USD | 95.297% |
| Viveve Medical, Inc. | 620 Thousand USD | -20524.839% |
| ZimVie Inc. | 290.38 Million USD | 55.964% |
| Movano Inc. | -158 Thousand USD | 81032.911% |
| Cytek Biosciences, Inc. | 109.42 Million USD | -16.859% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -150233.882% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 65.222% |
| Profound Medical Corp. | 4.51 Million USD | -2732.818% |
| Insulet Corporation | 1.15 Billion USD | 88.975% |
| enVVeno Medical Corporation | -546 Thousand USD | 23520.147% |
| Surmodics, Inc. | 93.05 Million USD | -37.422% |
| iCAD, Inc. | 14.53 Million USD | -779.706% |
| Nuwellis, Inc. | 4.98 Million USD | -2466.205% |
| Biotricity, Inc. | 8.35 Million USD | -1430.274% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 61.461% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 35713.844% |
| InspireMD, Inc. | 1.8 Million USD | -6976.591% |
| PAVmed Inc. | -3.96 Million USD | 3322.631% |
| BIOLASE, Inc. | 16.72 Million USD | -664.614% |
| Beyond Air, Inc. | -1.3 Million USD | 9883.78% |
| FONAR Corporation | 45.14 Million USD | -183.283% |
| Vivani Medical, Inc. | -357 Thousand USD | 35919.048% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 34.468% |
| Inari Medical, Inc. | 434.56 Million USD | 70.574% |
| UFP Technologies, Inc. | 112.22 Million USD | -13.944% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -1021339.412% |
| Tenon Medical, Inc. | 1.24 Million USD | -10204.11% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 157969.136% |
| Co-Diagnostics, Inc. | 2.62 Million USD | -4767.517% |
| AdaptHealth Corp. | 479.56 Million USD | 73.335% |
| Sintx Technologies, Inc. | 1.84 Million USD | -6838.361% |
| NanoVibronix, Inc. | 1.53 Million USD | -8219.714% |
| Quanterix Corporation | 70.64 Million USD | -81.007% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 31596.059% |
| Sensus Healthcare, Inc. | 14.06 Million USD | -809.488% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | -142.277% |
| TransMedics Group, Inc. | 154.09 Million USD | 17.015% |
| ReWalk Robotics Ltd. | 4.45 Million USD | -2771.637% |
| NeuroMetrix, Inc. | 3.94 Million USD | -3139.438% |
| Hyperfine, Inc. | 4.75 Million USD | -2588.123% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | -19.534% |
| Biomerica, Inc. | 611 Thousand USD | -20828.642% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | -206.745% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 16474.055% |
| Silk Road Medical, Inc | 127.08 Million USD | -0.62% |